BRIEF-Teva Pharmaceutical reaffirms 2013 outlook
Feb 7 (Reuters) - Teva Pharmaceutical Industries Chief Financial Officer Eyal Desheh says:
* Reiterates 2013 revenue forecast $19.5-$20.5 bln, adjusted EPS $4.85-$5.15
- Thai PM calls snap election, protesters want power now |
- North Korea says Kim's powerful uncle dismissed for 'criminal acts'
- Protesters fell Lenin statue, tell Ukraine's president 'you're next'
- Storm pushes up U.S. East Coast after deep-freeze in the South
- Venezuela's Maduro to raise pressure on business after local vote